Skip to main content
. 2021 Sep 17;12:742349. doi: 10.3389/fphar.2021.742349

FIGURE 1.

FIGURE 1

Candidate targets of a PPI network of Pachyman in treating HCC for identifying pharmacological and pathological biotargets.